Benchmark Reiterates Speculative Buy on Orgenesis, Maintains $6 Price Target
BenzingaJun 14, 2023 07:52 ET
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Orgenesis (ORGS) and BELLUS Health (BLU)
TipRanksMar 22, 2023 12:37 ET